Sigachi Industries Limited has informed the Exchange regarding a press release dated April 28, 2025, titled "Signing of a Memorandum of Understanding (MoU) between Sigachi Industries Limited and Respilon Group sro".
SIGACHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sigachi Industries' wholly owned subsidiary, Sigachi MENA FZCO, has signed a Memorandum of Understanding with Czech-based Respilon Group s.r.o to collaborate on advanced drug delivery solutions using Respilon's proprietary NUENEX® nanofiber technology. The partnership will focus on developing, manufacturing, and commercializing nanofiber-based delivery formats such as Invisible Patches and powder-based pharmaceutical products, as well as API encapsulation strategies. The MoU was signed on April 24, 2025, in a formal ceremony between the MD of Sigachi MENA and Respilon's Chief Business Officer. This move aligns with Sigachi's broader strategy to expand into next-generation pharmaceutical technologies and follows the company's existing footprint in APIs, excipients, and intermediates across 65+ countries.
For shareholders, this signals Sigachi's entry into a high-growth, innovation-led segment (nanofiber drug delivery) through a technology partnership rather than a costly acquisition, potentially opening new revenue streams in advanced pharma delivery. The market may view the international tie-up with a specialized European R&D firm positively, though MoUs are preliminary and execution risks remain.